FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
Hamza M. Al-tamari(Max Planck Institute for Heart and Lung Research), Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Jihye Paik(Meyer (China)), Swati Dabral(University of Würzburg), Oliver Eickelberg(Ludwig-Maximilians-Universität München), Werner Seeger(Justus-Liebig-Universität Gießen), Clemens Ruppert(German Center for Lung Research), Rajkumar Savai(Goethe University Frankfurt), Pouya Sarvari(Max Planck Institute for Heart and Lung Research), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Anja Schmall(Max Planck Institute for Heart and Lung Research), Andreas Günther(Cardio-Pulmonary Institute), Ronald A. DePinho(The University of Texas MD Anderson Cancer Center)
Cited by 121
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Genetics and biology of pancreatic ductal adenocarcinoma
|Genes & Development|2006|1.6k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k